Applications of 2-Fluoroethyl 4-Methylbenzenesulfonate in Industrial Manufacturing

As a direct manufacturer of 2-Fluoroethyl 4-Methylbenzenesulfonate, we supply this intermediate to multiple industrial sectors. It plays a critical role in specialized chemical synthesis processes, especially in the pharmaceutical, agrochemical, and advanced material industries. Our technical team works closely with integrators and formulators to ensure safe, consistent, and compliant downstream usage.

1. Pharmaceutical API Synthesis – Fluoroalkylation Reagent

Producers of active pharmaceutical ingredients (APIs) use this product for introducing fluoroalkyl groups during late-stage synthesis. It acts as an alkylating agent in manufacturing precision fluorinated molecules, including kinase inhibitors and CNS-targeted compounds. Operators optimize reaction conditions to achieve high purity and minimized by-products, crucial for registration-grade pharmaceutical outputs.

Industry compliance standards

• ICH Q7 GMP for Active Pharmaceutical Ingredients
• European Pharmacopeia (Ph. Eur.) Monographs
• US FDA 21 CFR Part 211, cGMP standards
• Japanese Pharmacopoeia (JP) when applicable

Typical usage ratio

• Applied at 0.4–1.2 equivalents relative to the nucleophilic substrate, with optimization per the target molecule structure and process scale.

Downstream process integration

• Charged during the late-stage alkylation reaction, typically under anhydrous conditions, after core scaffold assembly and before final purification.

Final product types

• Targeted small molecule APIs with fluorinated functional groups
• Key drug intermediates for oncology and CNS therapies

2. Agrochemical Intermediate Functionalization

In crop protection synthesis, formulators use this material to introduce efficient fluoro-functional handles on core herbicide and fungicide intermediates. The resulting derivatives improve bioactivity or soil persistence and support downstream formulation efficiency. Scale-up processes require high batch reproducibility and trace metal impurity controls for regulatory submissions.

Industry compliance standards

• OECD Principles of Good Laboratory Practice (GLP)
• Regulation (EC) No 1107/2009 on plant protection products (EU)
• US EPA PRIA Data Guidelines (OPPTS series)
• ISO 9001:2015 for process quality management

Typical usage ratio

• 0.5–1.4 molar equivalents versus active intermediate depending on targeted final molecule and conversion efficiency requirements.

Downstream process integration

• Added during nucleophilic substitution or cross-coupling step following base scaffold synthesis, prior to formulation into technical concentrate.

Final product types

• Herbicide and fungicide precursors with enhanced fluorination
• Active ingredients for high-performance crop protection agents

3. Specialty Fluorinated Monomer Manufacturing

Advanced material producers employ this sulfonate ester in the synthesis of fluoro-functionalized monomers for specialty polymer or copolymer production. The reactivity enables efficient introduction of 2-fluoroethyl moieties onto aromatic rings, supporting high-performance polymer properties, such as increased thermal stability and unique dielectric profiles.

Industry compliance standards

• REACH Regulation (EC) No 1907/2006 for chemical registration
• ISO 9001:2015 certified production workflows
• ASTM D5630 for residue analysis in polymers
• Appropriate regional chemical workplace safety protocols

Typical usage ratio

• 0.8–1.3 molar equivalents per key aromatic substrate, with adjustment for desired monomer purity and side-reaction suppression.

Downstream process integration

• Utilized at the alkylation phase after initial core assembly, immediately before subsequent chain extension or polymerization steps.

Final product types

• Fluoro-containing monomers for high-performance polymers
• Advanced resins for coatings and electronics manufacturing

4. Radiochemistry – Synthesis of Fluorine-18 Labeling Precursors

Radiopharmaceutical manufacturers value this compound for preparing [18F]-labeled synthetic building blocks. During production of PET imaging tracers, it acts as a key leaving group for nucleophilic [18F]fluorine substitution reactions. Stringent control of impurities and radiochemical yield is paramount for clinical-grade tracer supply.

Industry compliance standards

• United States Pharmacopeia (USP) & European Pharmacopeia standards for radiopharmaceuticals
• Good Manufacturing Practice for Radiopharmaceuticals – EU GMP Annex 3
• FDA 21 CFR Part 212 (PET Drugs: CGMP)
• International Atomic Energy Agency (IAEA) safety protocols

Typical usage ratio

• 1:1 molar ratio to precursor substrate, adjusted for radioactivity levels and tracer synthesis route.

Downstream process integration

• Introduced in the labeling step directly prior to purification and formulation of PET tracers, ensuring minimal unreacted precursor in the final product.

Final product types

• [18F]-labeled PET imaging agents
• Synthetic intermediates for clinical and preclinical radiotracer kits

5. Fine Chemical Custom Synthesis

Chemical contract research organizations (CROs) and specialty manufacturers integrate this product into multi-step syntheses requiring selective fluoroethyl group transfer. It serves in the preparation of tailored building blocks for high-value fine chemicals, especially where downstream function depends on specific substitution patterns. Batch records require detailed traceability and process reproducibility to meet contract specifications.

Industry compliance standards

• ISO 9001:2015 for custom synthesis and analytical quality management
• REACH and TSCA inventory reporting for new chemical substances
• Code of Federal Regulations (CFR) Title 40 for chemical manufacturing
• Client-specific NDA and confidentiality systems

Typical usage ratio

• 0.7–1.5 equivalents per functional group targeted, fine-tuned by chemist according to reaction pathway and downstream requirements.

Downstream process integration

• Incorporated during tailored alkylation steps on customer molecules, often after multi-step protection and deprotection sequences.

Final product types

• Fluoro-functional intermediates for specialty chemical customers
• Advanced research samples for pharmaceutical and materials R&D